Schizophrenia: vulnerability versus disease.
One of the most important trends in the treatment of schizophrenia involves its early diagnosis and intervention. The ultimate goal of research is the prevention of the disorder, A major impediment to the development of prevention strategies, however, is that we do not yet know what the liability for schizophrenia is before the onset of psychosis. Consequently, early treatment attempts are focused on the "prodrome," which involves the early symptoms of psychosis. In a companion paper, we recently suggested that prevention work should focus not only on the prodrome, but also on "schizotaxia," which is a clinically meaningful condition that may reflect the vulnerability to schizophrenia in the absence of psychosis. Because schizotaxia can be assessed prior to the prodrome, studies of schizotaxia might lead to more effective prevention programs. We continue the characterization of schizotaxia in this paper by focusing on the etiological roots of schizotaxia, plus its likely neurodevelopmental course, clinical expression, and treatment. Finally, the importance of including neurobiological variables in the conceptualization and eventual diagnosis of schizotaxia is reviewed.
Harvard Medical School Department of Psychiatry at the Massachusetts Mental Health Center; Brockton West Roxbury Veterans Affairs Medical Center; Harvard Institute of Psychiatric Epidemiology and Genetics, Boston, Mass, USA; Department of Epidemiology, Harvard School of Public Health, Boston, Mass, USA.
M T
MT
Tsuang
W S
WS
Stone
S V
SV
Faraone